Mesa Laboratories, Inc. (MLAB)
134.27
-4.74
(-3.41%)
USD |
NASDAQ |
Nov 16, 16:00
134.27
0.00 (0.00%)
After-Hours: 18:33
Mesa Laboratories Net Income (Quarterly) : 4.341M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 4.341M |
| June 30, 2026 | 2.83M |
| March 31, 2026 | -4.136M |
| December 31, 2025 | 3.63M |
| September 30, 2025 | 2.476M |
| June 30, 2025 | 4.742M |
| March 31, 2025 | -7.114M |
| December 31, 2024 | -1.676M |
| September 30, 2024 | 3.428M |
| June 30, 2024 | 3.388M |
| March 31, 2024 | -254.58M |
| December 31, 2023 | 2.116M |
| September 30, 2023 | -1.23M |
| June 30, 2023 | -0.549M |
| March 31, 2023 | 0.611M |
| December 31, 2022 | 0.451M |
| September 30, 2022 | 1.306M |
| June 30, 2022 | -1.438M |
| March 31, 2022 | -1.784M |
| December 31, 2021 | -2.06M |
| September 30, 2021 | 3.72M |
| June 30, 2021 | 1.995M |
| March 31, 2021 | 3.92M |
| December 31, 2020 | -4.542M |
| September 30, 2020 | 2.679M |
| Date | Value |
|---|---|
| June 30, 2020 | 1.217M |
| March 31, 2020 | -1.552M |
| December 31, 2019 | -4.504M |
| September 30, 2019 | 3.172M |
| June 30, 2019 | 4.597M |
| March 31, 2019 | 1.402M |
| December 31, 2018 | 0.858M |
| September 30, 2018 | 0.994M |
| June 30, 2018 | 4.23M |
| March 31, 2018 | 4.254M |
| December 31, 2017 | -11.09M |
| September 30, 2017 | 2.353M |
| June 30, 2017 | 1.517M |
| March 31, 2017 | 3.643M |
| December 31, 2016 | 3.252M |
| September 30, 2016 | 2.358M |
| June 30, 2016 | 1.93M |
| March 31, 2016 | 3.991M |
| December 31, 2015 | 2.597M |
| September 30, 2015 | 1.752M |
| June 30, 2015 | 2.306M |
| March 31, 2015 | 2.239M |
| December 31, 2014 | 2.403M |
| September 30, 2014 | 3.06M |
| June 30, 2014 | 1.881M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 362.00M |
| Bio-Rad Laboratories, Inc. | 458.60M |
| Bruker Corp. | -109.70M |
| Danaher Corp. | 1.207B |
| Harvard Bioscience, Inc. | -2.623M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 62.34M |
| Total Expenses (Quarterly) | 58.00M |
| EPS Diluted (Quarterly) | 0.7536 |
| Enterprise Value | 907.59M |
| Gross Profit Margin (Quarterly) | 57.36% |
| Profit Margin (Quarterly) | 6.96% |
| Earnings Yield | 0.86% |
| Operating Earnings Yield | 3.44% |
| Normalized Earnings Yield | 0.8576 |